A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
Clinical trial NCT03561740 · RECRUITING
Trial details
- NCT number
- NCT03561740
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2023-06-15
- Enrollment
- 794
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.